Cargando…

XRCC3 Thr241Met Polymorphism and Clinical Outcomes of NSCLC Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis

INTRODUCTION: X-ray repair cross-complementing protein 3 (XRCC3) is an essential gene involved in the double-strand break repair pathway. Published evidence has shown controversial results about the relationship between XRCC3 Thr241Met polymorphism and clinical outcomes of non-small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Xiao-yong, Lu, Fan-zhen, Wu, Yun, Zhao, Li-ting, Lin, Zhi-feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734199/ https://www.ncbi.nlm.nih.gov/pubmed/23940523 http://dx.doi.org/10.1371/journal.pone.0069553

Ejemplares similares

XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis
por: Yan, Yulan, et al.
Publicado: (2013)

XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis
por: Zhan, Ping, et al.
Publicado: (2013)

XRCC3 Thr241Met Is Associated with Response to Platinum-Based Chemotherapy but Not Survival in Advanced Non-Small Cell Lung Cancer
por: Qiu, Mantang, et al.
Publicado: (2013)

XRCC3 Thr241Met Polymorphism is not Associated with Lung Cancer Risk in a Romanian Population
por: CATANA, ANDREEA, et al.
Publicado: (2016)

Association between the XRCC3 Thr241Met Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis
por: Sahami-Fard, Mohammad Hossein, et al.
Publicado: (2016)

A literature review and systematic meta-analysis on XRCC3 Thr241Met polymorphism associating with susceptibility of oral cancer
por: Fan, Jianlin, et al.
Publicado: (2019)

Ethnicity-stratified analysis of the association between XRCC3 Thr241Met polymorphism and leukemia: an updated meta-analysis
por: Xie, Zhengjun, et al.
Publicado: (2021)

Association Between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies
por: Chai, Fan, et al.
Publicado: (2015)

Association between XRCC3 p.Thr241Met polymorphism and risk of glioma: A systematic review and meta-analysis
por: Tan, Shing Cheng, et al.
Publicado: (2022)

DNA repair gene XRCC3 Thr241Met polymorphism and susceptibility to glioma: A case-control study
por: XU, GAOFENG, et al.
Publicado: (2014)

XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer
por: He, Yanjing, et al.
Publicado: (2018)

Association of XRCC3 18067 C>T (Thr241Met) polymorphism with risk of cervical and ovarian cancers: A systematic review and meta-analysis
por: Karimi-Zarchi, Mojgan, et al.
Publicado: (2019)

Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies
por: Dashti, Sepideh, et al.
Publicado: (2019)

Association Between X-Ray Cross-Complementing Group 3 (XRCC3) Thr241Met Polymorphism and Risk of Thyroid Cancer: A Meta-Analysis
por: Lu, Wenying, et al.
Publicado: (2015)

Comment on: “Association Between the XRCC3 Thr241Met Polymorphism and Risk of Colorectal Cancer: A Meta-Analysis of 5,193 Cases and 6,645 Controls”
por: Sahami-Fard, Mohammad Hossein, et al.
Publicado: (2016)

DNA Repair Mechanism Gene, XRCC1A (Arg194Trp) but not XRCC3 (Thr241Met) Polymorphism Increased the Risk of Breast Cancer in Premenopausal Females: A Case–Control Study in Northeastern Region of India
por: Devi, K. Rekha, et al.
Publicado: (2017)

Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis
por: Zhang, Ningning, et al.
Publicado: (2020)

Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement
por: Li, Dan-Juan, et al.
Publicado: (2017)

Myocardial Infarction and AGT p.Thr174Met Polymorphism: A Meta-Analysis of 7657 Subjects
por: Li, Yan-yan, et al.
Publicado: (2021)

XRCC1 polymorphism and overall survival in ovarian cancer patients treated with platinum-based chemotherapy: A systematic review and MOOSE-compliant meta-analysis
por: Zhang, Zhuo, et al.
Publicado: (2018)

A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer
por: Mandegari, Mohammad, et al.
Publicado: (2021)

Polymorphisms of CCNB1 Associated With the Clinical Outcomes of Platinum-Based Chemotherapy in Chinese NSCLC Patients
por: Liu, Di, et al.
Publicado: (2017)

Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
por: Kaur, Jagjeet, et al.
Publicado: (2020)

ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy
por: Liblab, Salisa, et al.
Publicado: (2020)

Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy
por: Zhao, Ming, et al.
Publicado: (2020)

Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy
por: Alvisi, Maria Francesca, et al.
Publicado: (2020)

Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy
por: Tan, Chia Jie, et al.
Publicado: (2018)

Delay of the Blink Reflex in Patients Receiving Platinum-Analogue Chemotherapy
por: Park, Kang Young, et al.
Publicado: (2016)

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2014)

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Zaanan, Aziz, et al.
Publicado: (2014)

Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B
por: Lu, Linna, et al.
Publicado: (2023)

Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy
por: Yuan, Zhengrong, et al.
Publicado: (2015)

Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysis
por: Chen, Juan, et al.
Publicado: (2016)

Polymorphisms of XRCC3 and XRCC7 and Colorectal Cancer Risk in Khorasan Razavi Province, Iran
por: Mehrzad, Jamshid, et al.
Publicado: (2019)

Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
por: Ozoran, Emre, et al.
Publicado: (2022)

The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma
por: Cheng, Xiao-Dong, et al.
Publicado: (2009)

PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer’s Disease
por: Yang, YoungSoon, et al.
Publicado: (2022)

IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients
por: Nishio, Makoto, et al.
Publicado: (2021)

Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancer
por: Yang, Na-Na, et al.
Publicado: (2017)

Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines
por: Geyik, Sırma, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_chd373efccgptdlvemrqcm6urc